Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
Matthew Pine, Gunjan Arora, Thomas Hart, et al.
Molecular Therapy (2023) Vol. 31, Iss. 9, pp. 2702-2714
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Functional probes for the diagnosis and treatment of infectious diseases
Zhijin Fan, Yan Liu, Yuyun Ye, et al.
Aggregate (2024)
Open Access | Times Cited: 21
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 16
An Overview of Nanoparticle-Based Delivery Platforms for mRNA Vaccines for Treating Cancer
Lin Yang, Xuehua Chen, Ke Wang, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 727-727
Open Access | Times Cited: 14
Development of mRNA Lipid Nanoparticles: Targeting and Therapeutic Aspects
Yaping Liu, Yingying Huang, Guantao He, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10166-10166
Open Access | Times Cited: 14
Advances in the design and delivery of RNA vaccines for infectious diseases
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 11
mRNA vaccine platforms to prevent bacterial infections
Carson Bergstrom, Nicholas O. Fischer, Jessica Z. Kubicek-Sutherland, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 6, pp. 524-526
Open Access | Times Cited: 10
Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice
M. Allison Wolf, Joanne M. O’Hara, Graham J. Bitzer, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Advances in Vaccine Development for Chlamydia trachomatis
Taylor B. Poston
Pathogens and Disease (2024) Vol. 82
Open Access | Times Cited: 6
Nanomaterials in Immunology: Bridging Innovative Approaches in Immune Modulation, Diagnostics, and Therapy
George-Alexandru Croitoru, Diana-Cristina Pîrvulescu, Adelina-Gabriela Niculescu, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 225-225
Open Access | Times Cited: 6
Advances in the study of LNPs for mRNA delivery and clinical applications
Bili Wang, Biao Shen, Wenqing Xiang, et al.
Virus Genes (2024) Vol. 60, Iss. 6, pp. 577-591
Closed Access | Times Cited: 5
The Platform Technology Approach to mRNA Product Development and Regulation
John Howard Skerritt, Carolyn Tucek-Szabo, Brett Sutton, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 528-528
Open Access | Times Cited: 4
Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective
Elizabeth González-Cueto, José de la Fuente, César López‐Camacho
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Vaccination to Prevent Lyme Disease: A Movement Towards Anti-Tick Approaches
Emily Johnson, Thomas Hart, Erol Fikrig
The Journal of Infectious Diseases (2024) Vol. 230, Iss. Supplement_1, pp. S82-S86
Open Access | Times Cited: 4
Identifying Opportunity Targets in Gram-Negative Pathogens for Infectious Disease Mitigation
Isaac Paddy, Laura M. K. Dassama
ACS Central Science (2025) Vol. 11, Iss. 1, pp. 25-35
Open Access
Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects
Zijing Wei, Shuai Zhang, Xingya Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Lyme disease mRNA vaccine targeting Borrelia burgdorferi Outer Surface Protein A (OspA) induces strong immune responses and prevents transmission in mice
Djamel Tahir, Virginie Geolier, Hugo Bruant, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 2, pp. 102514-102514
Open Access
A strategy for synergistic enhancement of immune circulation in head and neck squamous cell carcinoma by novel nucleic acid drug therapy and immunotherapy
Yue Hong, Yanyang Liu, Huize Shen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Engineering Lipid Nanoparticles for mRNA Immunotherapy
Robby Zwolsman, Y. Darwish, Ewelina Kluza, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 2
Open Access
Targeted delivery of circPDHK1 siRNA via aptamer functionalized lipid nanoparticles inhibits ccRCC growth and migration
H Ning, Yan Jiang, Binbin Li, et al.
International Journal of Pharmaceutics (2025), pp. 125666-125666
Closed Access
The Development of a Rabies Virus-Vectored Vaccine against Borrelia burgdorferi, Targeting BBI39
Shantel Rios, Bibek Bhattachan, Kruthi Vavilikolanu, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 78-78
Open Access | Times Cited: 3
Single-domain antibodies reveal unique borrelicidal epitopes on the Lyme disease vaccine antigen, outer surface protein A (OspA)
David J. Vance, Saiful Basir, Carol Lyn Piazza, et al.
Infection and Immunity (2024) Vol. 92, Iss. 4
Open Access | Times Cited: 3
Analytical Ultracentrifugation to Assess the Quality of LNP-mRNA Therapeutics
Giuditta Guerrini, Dóra Méhn, Diletta Scaccabarozzi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5718-5718
Open Access | Times Cited: 3
Novel Administration Routes, Delivery Vectors, and Application of Vaccines Based on Biotechnologies: A Review
Chung-I Rai, Tsu-Hsiang Kuo, Yuan‐Chuan Chen
Vaccines (2024) Vol. 12, Iss. 9, pp. 1002-1002
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top